share_log

StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

斯托克新聞網開始對BIOLASE進行報道(納斯達克：Biol)
kopsource ·  2022/11/28 15:12

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research note published on Friday morning. The firm issued a sell rating on the medical technology company's stock.

斯托克新聞網在週五上午發佈的一份研究報告中對BIOLASE(納斯達克：BIOL-GET評級)的股票進行了報道。該公司對這家醫療技術公司的股票發佈了賣出評級。

Several other brokerages have also commented on BIOL. Maxim Group decreased their price objective on shares of BIOLASE from $10.00 to $5.00 in a report on Friday, November 11th. Benchmark decreased their price objective on shares of BIOLASE to $7.00 in a report on Wednesday, November 16th. Finally, Ascendiant Capital Markets decreased their price objective on shares of BIOLASE to $14.00 in a report on Wednesday, November 16th.

其他幾家券商也對Biol發表了評論。Maxim Group在11月11日星期五的一份報告中將BIOLASE的股票目標價從10.00美元下調至5.00美元。基準在11月16日星期三的一份報告中將BIOLASE的股票目標價下調至7.00美元。最後，Ascaldiant Capital Markets在11月16日星期三的一份報告中將BIOLASE的股票目標價下調至14.00美元。

Get
到達
BIOLASE
生物酶
alerts:
警報：

BIOLASE Stock Up 4.6 %

Biolase股票上漲4.6%

Shares of NASDAQ BIOL opened at $1.02 on Friday. The company has a current ratio of 2.46, a quick ratio of 1.27 and a debt-to-equity ratio of 0.92. BIOLASE has a 12 month low of $0.93 and a 12 month high of $13.83. The firm has a market capitalization of $7.25 million, a PE ratio of -0.28 and a beta of 1.45. The firm has a fifty day simple moving average of $2.01 and a two-hundred day simple moving average of $3.51.

上週五，納斯達克生物的股價開盤報1.02美元。該公司的流動比率為2.46，速動比率為1.27，債務權益比率為0.92。Biolase的12個月低點為0.93美元，12個月高位為13.83美元。該公司市值為725萬美元，市盈率為-0.28，貝塔係數為1.45。該公司的50日簡單移動均線切入位在2.01美元，200日簡單移動均線切入位在3.51美元。

Institutional Inflows and Outflows

機構資金流入和流出

Institutional investors have recently modified their holdings of the business. Commonwealth Equity Services LLC increased its stake in shares of BIOLASE by 117.8% in the 1st quarter. Commonwealth Equity Services LLC now owns 101,046 shares of the medical technology company's stock worth $35,000 after acquiring an additional 54,650 shares in the last quarter. Capital Wealth Alliance LLC purchased a new stake in BIOLASE during the 2nd quarter valued at about $51,000. Citadel Advisors LLC purchased a new stake in BIOLASE during the 2nd quarter valued at about $118,000. State Street Corp grew its position in BIOLASE by 4.5% during the 1st quarter. State Street Corp now owns 436,076 shares of the medical technology company's stock valued at $154,000 after purchasing an additional 18,682 shares during the last quarter. Finally, Essex Investment Management Co. LLC grew its position in BIOLASE by 62.3% during the 3rd quarter. Essex Investment Management Co. LLC now owns 105,318 shares of the medical technology company's stock valued at $256,000 after purchasing an additional 40,440 shares during the last quarter. 21.21% of the stock is currently owned by institutional investors.
機構投資者最近調整了對該公司的持股。英聯邦股票服務有限責任公司在第一季度增持了117.8%的BIOLASE股票。Federal Equity Services LLC現在持有這家醫療技術公司101,046股股票，價值35,000美元，上個季度又收購了54,650股。資本財富聯盟有限責任公司在第二季度購買了BIOLASE的新股份，價值約51,000美元。Citadel Advisors LLC在第二季度購買了BIOLASE的新股份，價值約11.8萬美元。道富集團第一季度在BIOLASE的頭寸增加了4.5%。道富集團目前持有436,076股這家醫療技術公司的股票，價值154,000美元，此前該公司在上個季度又購買了18,682股。最後，埃塞克斯投資管理有限公司在第三季度將其在BIOLASE的頭寸增加了62.3%。Essex Investment Management Co.LLC現在持有這家醫療技術公司105,318股股票，價值25.6萬美元，該公司在上個季度又購買了40,440股票。該公司21.21%的股票目前由機構投資者持有。

BIOLASE Company Profile

Biolase公司簡介

(Get Rating)

(獲取評級)

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications.

Biolase公司與其子公司一起，在美國和國際上為牙科醫生及其患者開發、製造、營銷和銷售激光系統。它的牙科激光系統允許牙醫、牙周病醫生、牙髓醫生、口腔外科醫生和其他牙科專家執行一系列微創牙科手術，如美容、修復和複雜的外科應用。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on BIOLASE (BIOL)
  • Best Buy Proves Brick and Mortar is Here to Stay
  • MarketBeat: Week in Review 11/21 – 11/25
  • Microsoft Shares: Is it Time to Back Up the Truck?
  • Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
  • Institutional Support for Analog Devices Remains High
  • 免費獲取StockNews.com關於BIOLASE的研究報告(Biol)
  • 百思買證明磚頭和砂漿將繼續存在
  • MarketBeat：回顧一週11/21-11/25
  • 微軟股票：是時候備份卡車了嗎？
  • Salesforce裁員，儘管面臨挑戰，但收入強勁
  • 機構對ADI的支持仍然很高

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.

接受《BIOLASE日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對BIOLASE和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論